title: Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease.
authors.forename: Waseem
authors.initials: W
authors.lastname: Qasim
authors.forename: Sophie
authors.initials: S
authors.lastname: Derniame
authors.forename: Kimberly
authors.initials: K
authors.lastname: Gilmour
authors.forename: Robert
authors.initials: R
authors.lastname: Chiesa
authors.forename: Martin
authors.initials: M
authors.lastname: Weber
authors.forename: Stuart
authors.initials: S
authors.lastname: Adams
authors.forename: Kanchan
authors.initials: K
authors.lastname: Rao
authors.forename: Persis
authors.initials: P
authors.lastname: Amrolia
authors.forename: Nicholas
authors.initials: N
authors.lastname: Goulden
authors.forename: Paul
authors.initials: P
authors.lastname: Veys
authors.forename: Hubert
authors.initials: H
authors.lastname: Gaspar
mesh_terms: D000257:Adenoviridae Infections / Q000628:therapy*; D019264:Adoptive Transfer / Q000009:adverse effects*; D024201:Bystander Effect; D002648:Child; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology*; D006801:Humans; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D013601:T-Lymphocytes / Q000637:transplantation*